Back

Inflammation and arterial hypertension are the main risk factors occurrence of AF in patients with heart failure patients with preserved ejection fraction (retrospective study)

12 May 2024 (13:34 - 14:42)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 4 Heart Failure in Atrial Fibrillation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Lusine Hazarapetyan

Yerevan MSC, Yerevan (Armenia)

6 More presentations in this session

Presentation thumbnail
Cardiovascular outcomes in hospitalized patients with atrial fibrillation. A one-year follow-up
Miss D. Islas Cortes (Ciudad De Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Diagnostic implication of left atrial stiffness index in evaluating of heart failure with preserved ejection fraction in patients with atrial fibrillation
Doctor F. Cabello Montoya (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Catheter treatment of atrial fibrillation in heart failure patients with systolic dysfunction: its influence on the course of chronic heart failure, 12 months follow up.
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides Video
Presentation thumbnail
Adherence to the Atrial Fibrillation (AF) Better Care (ABC) pathway among AF patients with heart failure (HF)
Doctor H. Zulkifly (Selangor, MY)
Abstract Slides Video
Presentation thumbnail
Quality of life in patients with atrial fibrillation taking into account the phenotype of heart failure
Associate Professor N. Kulaiets (Ivano-Frankivsk, UA)
Abstract Slides

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 4

The Event

Event poster

Heart Failure 2024

12 May 2024 13:34 CET
You may be interested in
thumbnail
Congress Presentation
Characterising the role of atrial fibrillation in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Inter-atrial block and atrial fibrillation predict cardiac adverse events in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Heart failure with preserved ejection fraction and incidence rate of atrial fibrillation: insights from a randomized clinical trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources